VelosBio
VelosBio is an oncology company, developing novel antibody-drug conjugates to treat hematological cancers. The company was acquired by Merck in November 2020.
Acquisition Transaction
Crunchbase URL
Investors
Latest Funding Round Date
2020
Latest Funding Round Amount (USD)
137,000,000
Latest Funding Type
LinkedIn URL
Location
Total Funding Amount (USD)
195,000,000
Official Website
Find more companies like VelosBio
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.